Hemo Organic Board approves MoA change, ₹125 Cr capital hike, new CS

Hemo Organic Ltd's Board of Directors, in a meeting on October 3, 2026, approved significant corporate actions. These include the alteration of the Main Objects clause of the Memorandum of Association to incorporate new business activities, such as dealing in diamonds and real estate, subject to shareholder and regulatory approvals. The Board also approved an increase in the Authorised Share Capital from ₹13,45,00,000 (₹13.45 Crore) to ₹125,00,00,000 (₹125 Crore), divided into 12.5 Crore equity shares of ₹10 each, also pending shareholder approval. Additionally, Ms. Pratibha Sharma was appointed as the Company Secretary and Compliance Officer. A proposal for raising funds was deferred to a subsequent board meeting.